Gambaran Umum
Cardiol Therapeutics Inc., headquartered in Canada, operates in the pharmaceutical industry and specializes in the research and development of anti-inflammatory therapies for the treatment of heart disease. A major focus for the company involves advancing proprietary formulations of pharmaceutical-grade cannabidiol and other supportive treatments. Notably, Cardiol is currently advancing clinical trials concerning its lead compound, targeting inflammatory heart diseases such as myocarditis, which could have significant implications for improving cardiac health outcomes. Additionally, they are exploring the potential of their technologies in oncology, aiming to innovate therapeutic solutions for glioblastoma, a highly aggressive form of brain cancer. These initiatives exemplify Cardiol Therapeutics' strategic focus on leveraging scientific and clinical research to develop novel, targeted therapies for critical healthcare needs.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Cardiol Therapeutics Inc. per 2025 Jun 30 adalah -40.24 MM.
- Nilai net income untuk Cardiol Therapeutics Inc. per 2025 Jun 30 adalah -37.55 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -40.24 | -37.55 | |
2025-03-31 | -40.30 | -35.79 | |
2024-12-31 | -40.28 | -36.68 | |
2024-09-30 | -38.32 | -36.14 | |
2024-06-30 | -31.83 | -29.34 | |
2024-03-31 | -30.40 | -30.22 | |
2023-12-31 | -29.79 | -28.13 | |
2023-09-30 | -30.85 | -28.01 | |
2023-06-30 | -36.42 | -30.05 | |
2023-03-31 | -39.33 | -29.07 | |
2022-12-31 | -41.34 | -30.93 | |
2022-09-30 | 0.00 | -45.34 | -29.67 |
2022-06-30 | 0.00 | -42.28 | -31.61 |
2022-03-31 | 0.08 | -39.47 | -31.68 |
2021-12-31 | 0.08 | -38.66 | -31.64 |
2021-09-30 | 0.08 | -35.19 | -35.05 |
2021-06-30 | 0.08 | -29.54 | -29.54 |
2021-03-31 | -26.64 | -26.60 | |
2020-12-31 | -20.69 | -20.64 | |
2020-09-30 | -14.08 | -14.03 | |
2020-06-30 | |||
2020-03-31 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | -0.53 | -0.53 |
2024-06-30 | -0.44 | -0.44 |
2024-03-31 | -0.46 | -0.46 |
2023-12-31 | -0.44 | |
2023-09-30 | -0.44 | -0.44 |
2023-06-30 | -0.47 | -0.47 |
2023-03-31 | -0.46 | -0.46 |
2022-12-31 | -0.49 | |
2022-09-30 | -0.49 | -0.49 |
2022-06-30 | -0.57 | -0.57 |
2022-03-31 | -0.63 | -0.63 |
2021-12-31 | -0.73 | |
2021-09-30 | -0.93 | -0.93 |
2021-06-30 | -0.84 | -0.84 |
2021-03-31 | -0.83 | -0.83 |
2020-12-31 | -0.69 | |
2020-09-30 | -0.50 | -0.50 |
2020-06-30 | -0.50 | -0.50 |
2020-03-31 | -0.51 | -0.51 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Cardiol Therapeutics Inc. per 2025 Jun 30 adalah -25.07 MM.
- Nilai cash from investing activities untuk Cardiol Therapeutics Inc. per 2025 Jun 30 adalah -0.03 MM.
- Nilai kas dari aktivitas pendanaan untuk Cardiol Therapeutics Inc. per 2025 Jun 30 adalah 18.69 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -25.07 | -0.03 | 18.69 |
2025-03-31 | -25.29 | -0.03 | 18.75 |
2024-12-31 | -25.06 | -0.02 | 18.84 |
2024-09-30 | -25.93 | -0.03 | 0.14 |
2024-06-30 | -21.58 | -0.02 | 0.13 |
2024-03-31 | -22.16 | -0.02 | 0.03 |
2023-12-31 | -25.18 | -0.06 | -0.06 |
2023-09-30 | -31.26 | -0.10 | -0.06 |
2023-06-30 | -29.54 | -0.11 | -0.06 |
2023-03-31 | -26.75 | -0.10 | -0.05 |
2022-12-31 | -27.22 | -0.07 | -0.05 |
2022-09-30 | -18.67 | -0.03 | 59.21 |
2022-06-30 | -23.36 | -0.03 | 61.56 |
2022-03-31 | -26.87 | -0.03 | 82.36 |
2021-12-31 | -23.54 | -0.01 | 93.44 |
2021-09-30 | -22.13 | -0.03 | 34.26 |
2021-06-30 | -18.73 | -0.02 | 32.03 |
2021-03-31 | -13.84 | -0.02 | 27.37 |
2020-12-31 | -9.13 | -0.04 | 16.30 |
2020-09-30 | -9.65 | -0.11 | 16.20 |
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/e untuk Cardiol Therapeutics Inc. pada 2025 Jun 30 adalah -4.44.
- p/libro untuk Cardiol Therapeutics Inc. pada 2025 Jun 30 adalah 9.04.
- p/tbv untuk Cardiol Therapeutics Inc. pada 2025 Jun 30 adalah 9.04.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | -4.44 | 9.04 | 9.04 |
2025-03-31 | -3.12 | 10.80 | 10.80 |
2024-12-31 | -4.27 | 14.79 | 14.79 |
2024-09-30 | -6.62 | 12.65 | 12.79 |
2024-06-30 | -6.18 | 9.31 | 9.39 |
2024-03-31 | -4.75 | 3.81 | 3.84 |
2023-12-31 | -2.60 | 2.09 | 2.10 |
2023-09-30 | -2.67 | 2.07 | 2.09 |
2023-06-30 | -2.84 | 2.20 | 2.21 |
2023-03-31 | -3.81 | 2.43 | 2.45 |
2022-12-31 | -3.74 | 1.89 | 1.90 |
2022-09-30 | -3.63 | 1.84 | 1.85 |
2022-06-30 | -3.41 | 1.71 | 1.72 |
2022-03-31 | -3.40 | 1.56 | 1.56 |
2021-12-31 | -5.76 | 2.39 | 2.40 |
2021-09-30 | -3.75 | 4.52 | 4.59 |
2021-06-30 | -4.35 | 3.81 | 3.85 |
2021-03-31 | -4.11 | 6.00 | 6.15 |
2020-12-31 | -4.76 | 7.40 | 7.67 |
2020-09-30 | -6.99 | 4.37 | 4.46 |
2020-06-30 | -7.47 | 3.75 | 3.83 |
2020-03-31 | -5.89 | 6.18 | 6.45 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Cardiol Therapeutics Inc. pada 2025 Jun 30 adalah -0.26.
- EBIT (3 tahun) / EV untuk Cardiol Therapeutics Inc. pada 2025 Jun 30 adalah -0.23.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.26 | -0.23 |
2025-03-31 | -0.37 | -0.33 |
2024-12-31 | -0.26 | -0.23 |
2024-09-30 | -0.17 | -0.17 |
2024-06-30 | -0.19 | -0.19 |
2024-03-31 | -0.30 | -0.33 |
2023-12-31 | -0.87 | -0.96 |
2023-09-30 | -0.85 | -0.86 |
2023-06-30 | -0.75 | -0.75 |
2023-03-31 | -0.47 | -0.47 |
2022-12-31 | -0.65 | -0.58 |
2022-09-30 | -0.70 | -0.62 |
2022-06-30 | -0.85 | -0.66 |
2022-03-31 | -0.96 | -0.72 |
2021-12-31 | -0.32 | -0.22 |
2021-09-30 | -0.34 | -0.22 |
2021-06-30 | -0.31 | -0.22 |
2021-03-31 | -0.29 | -0.21 |
2020-12-31 | -0.25 | -0.20 |
2020-09-30 | -0.17 | -0.16 |
2020-06-30 | -0.17 | -0.16 |
2020-03-31 | -0.18 | -0.15 |
Efektivitas Manajemen
- roa untuk Cardiol Therapeutics Inc. pada 2025 Jun 30 adalah -1.36.
- roe untuk Cardiol Therapeutics Inc. pada 2025 Jun 30 adalah -2.33.
- roic untuk Cardiol Therapeutics Inc. pada 2025 Jun 30 adalah -2.02.
- croic untuk Cardiol Therapeutics Inc. pada 2025 Jun 30 adalah -0.30.
- ocroic untuk Cardiol Therapeutics Inc. pada 2025 Jun 30 adalah -1.43.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -1.36 | -2.33 | -2.02 | -0.30 | -1.43 |
2025-03-31 | -1.16 | -1.80 | -3.41 | -2.33 | -2.45 |
2024-12-31 | -0.98 | -1.30 | -3.41 | -2.33 | -2.45 |
2024-09-30 | -0.68 | -1.04 | -1.89 | -1.35 | -1.39 |
2024-06-30 | -0.57 | -0.66 | -1.49 | -1.03 | -1.10 |
2024-03-31 | -0.45 | -0.54 | -0.80 | -0.71 | -0.89 |
2023-12-31 | -0.41 | -0.48 | -0.80 | -0.71 | -0.89 |
2023-09-30 | -0.40 | -0.48 | -0.77 | -0.66 | -0.76 |
2023-06-30 | -0.40 | -0.48 | -0.77 | -0.66 | -0.76 |
2023-03-31 | -0.37 | -0.42 | -0.64 | -0.56 | -0.59 |
2022-12-31 | -0.94 | -1.02 | -0.50 | 0.63 | -0.38 |
2022-09-30 | -0.94 | -1.02 | -0.50 | 0.63 | -0.38 |
2022-06-30 | -0.86 | -0.94 | -0.50 | 0.60 | -0.38 |
2022-03-31 | -1.50 | -1.74 | -0.46 | 0.82 | -0.37 |
2021-12-31 | -1.99 | -2.38 | -0.41 | 0.92 | -0.31 |
2021-09-30 | -1.43 | -1.56 | -1.20 | 0.41 | -0.76 |
2021-06-30 | -1.08 | -1.13 | -0.87 | 0.39 | -0.55 |
2021-03-31 | -1.99 | -2.12 | -1.45 | 0.73 | -0.75 |
2020-12-31 | -1.33 | -1.41 | -1.54 | 0.53 | -0.68 |
2020-09-30 | -0.77 | -0.84 | -0.62 | 0.28 | -0.43 |
2020-06-30 | -0.64 | -0.67 | -0.50 | 0.27 | -0.33 |
2020-03-31 | -0.57 | -0.60 | -1.03 | -0.77 | -0.77 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | 1.00 | -402.27 | -501.18 |
2021-12-31 | 1.00 | -401.70 | -490.92 |
2021-09-30 | 1.00 | -444.99 | -423.80 |
2021-06-30 | 1.00 | -375.05 | -349.76 |
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) |